酪氨酸蛋白激酶受體B1+B2+B3+B4抗體
規(guī)格：1mg/1ml
英文名： EphB1+EphB2+EphB3+EphB4
別名： CAPB; DRT; EK2; EK5; EK6; ELK; elk related tyrosine kinase; EPH like kinase 2; EPH like kinase 6; EPH like tyrosine kinase 2; eph tyrosine kinase 2; eph tyrosine kinase 3; EPH-like kinase 6; Ephb1; EP
分子量： 110kDa
儲(chǔ)存液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce
克隆類(lèi)型：Polyclonal
亞型：IgG
純化方法：affinity purified by Protein A
**原：KLH conjugated synthetic peptide derived from human EphB1+Ep
交叉反應(yīng)：Human,
細(xì)胞定位：
酪氨酸蛋白激酶受體B1+B2+B3+B4抗體產(chǎn)品介紹：background: Receptor for members of the ephrin-B family. Binds to ephrin-B1, -B2 and -B3. Binding with the guidance cue ephrin-B2 at the optic chiasm midline redirect ventrotemporal (VT) 酪氨酸蛋白激酶受體B1+B2+B3+B4抗體retinal ganglion cells (RGCs) axons ipsilaterally. May be involved in cell-cell interactions in the nervous system. Important Note: This product as supplied is intended for research use only, not for use in human,酪氨酸蛋白激酶受體B1+B2+B3+B4抗體 therapeutic or diagnostic applications.
酪氨酸蛋白激酶受體B1+B2+B3+B4抗體產(chǎn)品應(yīng)用：WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
研究領(lǐng)域：腫瘤 心血管 細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶 細(xì)胞膜受體
儲(chǔ)存條件： Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
來(lái)源： Rabbit
外觀： Lyophilized or Liquid
- 溫馨提示：為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn)，建議您在購(gòu)買(mǎi)前務(wù)必確認(rèn)供應(yīng)商資質(zhì)與產(chǎn)品質(zhì)量。
- 免責(zé)申明：以上內(nèi)容為注冊(cè)會(huì)員自行發(fā)布，若信息的真實(shí)性、合法性存在爭(zhēng)議，平臺(tái)將會(huì)監(jiān)督協(xié)助處理，歡迎舉報(bào)